BioLine RX Ltd ADR buy BiotechBee
Start price
03.09.23
/
50%
€1.97
Target price
31.07.25
€2.50
Performance (%)
18.78%
End price
06.09.23
€2.34
Summary
This prediction ended on 06.09.23 with a price of €2.34. The prediction had a final performance of 18.78%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioLine RX Ltd ADR | - | - | - |
| iShares Core DAX® | -0.559% | 0.738% | 14.807% |
| iShares Nasdaq 100 | -0.566% | -0.324% | 3.991% |
| iShares Nikkei 225® | 1.073% | 5.624% | 19.546% |
| iShares S&P 500 | 0.868% | 0.030% | 1.475% |
According to BiotechBee what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year